Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Qualifying Conditions Of Medical Cannabis License Holders In The United States
Kevin F. Boehnke, Saurav Gangopadhyay, Daniel J. Clauw, et al.
Health Affairs (2019) Vol. 38, Iss. 2, pp. 295-302
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
Arun Bhaskar, Alan Bell, Michael Boivin, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 115
U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020
Kevin F. Boehnke, Owen Dean, Rebecca L. Haffajee, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. 945-951
Open Access | Times Cited: 70
Sex differences and the endocannabinoid system in pain
Henry Blanton, Robert C. Barnes, Melissa C. McHann, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 202, pp. 173107-173107
Open Access | Times Cited: 96
Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain
Kevin F. Boehnke, J. Ryan Scott, Evangelos Litinas, et al.
Journal of Pain (2019) Vol. 20, Iss. 11, pp. 1362-1372
Open Access | Times Cited: 75
Attitudes toward medical cannabis among family physicians practising in Ontario, Canada: a qualitative research study
Jeremy Y. Ng, Kevin Gilotra, Sana Usman, et al.
CMAJ Open (2021) Vol. 9, Iss. 2, pp. E342-E348
Open Access | Times Cited: 56
The role of stigma in cannabis use disclosure: an exploratory study
Daniel D. King, Christopher Gill, Carey S. Cadieux, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022
Kevin F. Boehnke, Rachel Sinclair, Felicia Gordon, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 4, pp. 458-466
Closed Access | Times Cited: 10
Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials
Haron M. Jeddi, Jason W. Busse, Behnam Sadeghirad, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e068182-e068182
Open Access | Times Cited: 9
Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential
Sabrina L. Botsford, Sharon Yang, Tony P. George
American Journal on Addictions (2019) Vol. 29, Iss. 1, pp. 9-26
Open Access | Times Cited: 64
Medical cannabis use in the United States: a retrospective database study
V. Kishan Mahabir, Jamil J. Merchant, Christopher J. Smith, et al.
Journal of Cannabis Research (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 53
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic
Kevin F. Boehnke, Jenna McAfee, Joshua M. Ackerman, et al.
International Journal of Drug Policy (2020) Vol. 92, pp. 103053-103053
Open Access | Times Cited: 51
Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
Kevin F. Boehnke, Evangelos Litinas, Brianna Worthing, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 48
Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey
Kevin F. Boehnke, Joel Gagnier, Lynne Matallana, et al.
Journal of Pain (2021) Vol. 22, Iss. 5, pp. 556-566
Open Access | Times Cited: 45
Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey
Kevin F. Boehnke, Joel Gagnier, Lynne Matallana, et al.
Journal of Pain (2021) Vol. 22, Iss. 11, pp. 1418-1428
Open Access | Times Cited: 42
Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot
Sarah D. Pennypacker, Katharine Cunnane, Mary Catherine Cash, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Jeremy D. Henson, Luis Vitetta, Sean Hall
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1167-1178
Open Access | Times Cited: 28
Increasing Use of Cannabis for Medical Purposes Among U.S. Residents, 2013–2020
Taeho Greg Rhee, Robert A. Rosenheck
American Journal of Preventive Medicine (2023) Vol. 65, Iss. 3, pp. 528-533
Open Access | Times Cited: 17
Medical Cannabis in the United States: Comparing 2017 and 2024 State Qualifying Conditions to the 2017 National Academies of Sciences Report
Elena Lynn Stains, Amy L. Kennalley, Maria Tian, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2025) Vol. 9, Iss. 2, pp. 100590-100590
Closed Access
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019
Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, et al.
Medical Cannabis and Cannabinoids (2021) Vol. 4, Iss. 1, pp. 21-42
Open Access | Times Cited: 39
Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019–2020 National Health and Resilience in Veterans Study
Melanie L. Hill, Mallory Loflin, Brandon Nichter, et al.
Addictive Behaviors (2021) Vol. 120, pp. 106963-106963
Closed Access | Times Cited: 32
The evolving culture of medical cannabis in Canada for the management of chronic pain
Hance Clarke, Mary‐Ann Fitzcharles
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Feasibility pilot of a novel coaching intervention to optimize cannabis use for chronic pain management among Veterans
Kevin F. Boehnke, Gabrielle E. Bowyer, Jenna McAfee, et al.
Journal of Cannabis Research (2025) Vol. 7, Iss. 1
Open Access
Molecular mechanisms and pharmacology of cannabinoids: from theory to practice
Marek Lapka
Klinická farmakologie a farmacie (2025) Vol. 38, Iss. 4, pp. 156-160
Open Access
The Pharmacology of Cannabinoids in Chronic Pain
Alonso Cortez-Resendiz, Timothy J Leiter, S. Riela, et al.
Medical Cannabis and Cannabinoids (2025)
Open Access
The Cost Effectiveness of Adjunctive Medical Cannabis Therapy in the Treatment of Moderate Post-Traumatic Stress Disorder
Mitchell L. Doucette, Dipak Hemraj, Douglas Macfarlan, et al.
Clinical Drug Investigation (2025)
Closed Access
Page 1 - Next Page

Scroll to top